Shalini Sharp is of Mirati Therapeutics, Inc.. Currently has a direct ownership of 0 shares of MRTX, which is worth approximately $0. The most recent transaction as insider was on Jan 23, 2024, when has been sold 16,222 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
0% 3M change
100.0% 12M change
Total Value Held $0

Shalini Sharp Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 23 2024
SELL
Sale (or disposition) back to the issuer
-
16,222 Reduced 100.0%
0 Common Stock
Dec 29 2023
BUY
Grant, award, or other acquisition
$399,970 $58.75 p/Share
6,808 Added 29.56%
16,222 Common Stock
Jan 20 2023
BUY
Grant, award, or other acquisition
-
4,444 Added 32.07%
9,414 Common Stock
Jan 14 2022
BUY
Grant, award, or other acquisition
-
2,546 Added 33.87%
4,970 Common Stock
Mar 26 2021
BUY
Grant, award, or other acquisition
-
2,424 Added 50.0%
2,424 Common Stock

Also insider at

RARE
Ultragenyx Pharmaceutical Inc. Healthcare
DTIL
PRECISION BIOSCIENCES INC Healthcare
NUVB
Nuvation Bio Inc. Healthcare
NBIX
NEUROCRINE BIOSCIENCES INC Healthcare
STRO
SUTRO BIOPHARMA, INC. Healthcare
OGN
Organon & Co. Healthcare
BGNE
BeiGene, Ltd. Healthcare
SS

Shalini Sharp

San Diego, CA

Track Institutional and Insider Activities on MRTX

Follow Mirati Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells MRTX shares.

Notify only if

Insider Trading

Get notified when an Mirati Therapeutics, Inc. insider buys or sells MRTX shares.

Notify only if

News

Receive news related to Mirati Therapeutics, Inc.

Track Activities on MRTX